Roderick Sanden, MD
Neuromusculoskeletal Medicine & OMM · Carmichael, CANPI 1952361412
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,162 of the $2,964 with a category attached, or 72.9%. 7 manufacturers reported payments, led by Stryker at 52.5% of the total. Reporting peaked in 2021 at $1,857 and has fallen 97.6% since, to $44 in 2022.
Across 22 payments — averaging $134.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Medtronic$1K
- Si-bone, Inc.$158
- Augmedics Inc.$90
- KCI USA, Inc.$53
- Wenzel Spine, Inc.$44
- plus $14 from 1 others
What the payments were for
- Travel & lodging$2,16273%
- Food & beverage$80227%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 11 | $1,556 |
| Medtronic | 6 | $1,049 |
| Si-bone, Inc. | 1 | $158 |
| Augmedics Inc. | 1 | $90 |
| KCI USA, Inc. | 1 | $53 |
| Wenzel Spine, Inc. | 1 | $44 |
| Alphatec Spine, Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVEREST SPINAL SYSTEM$1,235
- O-ARM-ST$780
- StealthStation$162
- iFuse Implant$158
- CASCADIA INTERBODY SYSTEM$125
How this compares
$2,964 in reported general payments places this provider in the 85th percentile of 113 neuromusculoskeletal medicine & omm providers in California.
See all neuromusculoskeletal medicine & omm providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 57 | $2,500 |
| Cyclobenzaprine Hcl | 20 | $430 |
| Gabapentin | 48 | $430 |
| Methocarbamol | 19 | $214 |
| Ibuprofen | 22 | $151 |
| Sertraline Hcl | 14 | $74 |
| Trazodone Hcl | 12 | $35 |
Paid to pharmacies, not to this prescriber.
Other neuromusculoskeletal medicine & omm in Carmichael
- Raffy MirzayanBaldwin Park$458K
- Dean MatsudaLos Angeles$452K
- Scott ShoemakerSan Diego$49K
- Narendra GurbaniBellflower$40K
- Kiran BathFullerton$20K
- Richard DellBellflower$15K
- Emil DionysianAnaheim$14K
- Richard HartmanSanta Barbara$6K
- Neil HarnessAnaheim$4K
- William OharaSan Diego$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.